| HOME >> BIOLOGY >> TECHNOLOGY |
Assets
Cash, cash equivalents and short-term
investments $10,307,261 $6,763,702
All other current assets 2,877,962 2,449,081
Property, plant, and equipment, net 1,553,000 1,431,749
Intangible assets, net 4,426,101 308,093
Deferred tax assets 96,399 93,819
Total assets $19,260,723 $11,046,444
Liabilities and Shareholders' Equity
Total current liabilities 2,477,318 2,005,608
Long-term debt - less current maturities 405,761 427,382
Deferred rent - less current portion 189,329 214,381
Accrued pension liability 346,838 596,026
Total liabilities 3,419,246 3,243,397
Total shareholders' equity 15,841,477 7,803,047
Total liabilities and shareholders'
equity $19,260,723 $11,046,444
UROPLASTY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine Months Ended December 31, 2007 and 2006
(Unaudited)
Nine Months Ended
December 31,
2007 2006
Cash flows from operating activities:
Net loss $(3,125,695) $(3,963,386)
Adjustments to reconcile net loss to
net cash used in operating activities:
Depreciation and amortization 796,748 223,048
Gain on disposal of equipment (2,769)
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2008 PR Newswire. All rights reserved |